	Awareness of Partial Loss is Essential in Interpreting Merlin Immunohistochemistry When Diagnosing Pleural Mesothelioma. Pathol Int Nabeshima K, Furukawa T, Hamasaki M, Kushitani K, Takeshima Y, Shimizu S, Hiroshima K, Takeda M, Ninomiya H, Takizawa K, Goto Y, Adachi M. PMID: 42885816 [PubMed - indexed for MEDLINE]
	KRAS G12S Positive Non-Small Cell Lung Cancer Mimicking KRAS G12C Positivity on the AmoyDx PCR Panel: A Case Report. Thorac Cancer Sakaguchi T, Ito K, Nishio M, Suzuki Y, Iketani A, Ushiro K, Hataji O. PMID: 42885664 [PubMed - indexed for MEDLINE]
	Nodule Dye-Localization Using Interventional Fluoroscopy for Image-Guided Sublobar Lung Resection. Thorac Cancer Wu YL, Kam KH, Liang CY, Lai YT, Jeng TH, Lee CC, Wu YF, Yang YC, Yang HY, Chang JM. PMID: 42885537 [PubMed - indexed for MEDLINE]
	CHCHD2 as a prognostic biomarker and therapeutic target in lung adenocarcinoma: Insights from panâ€‘cancer multiâ€‘omics and functional studies. Oncol Rep Xu Z, Shen J, Lin Y, Shi H, Zhang C, Zhang Z, Zhou X, Yang Z. PMID: 42885315 [PubMed - indexed for MEDLINE]
	Large Carinal Chondrosarcoma: Resection of the Main Carina, Distal Trachea, and Orifices of the Mainstem Bronchi and Construction of a New Carina. Am J Case Rep Viskos DI, Pantazis IP, Danglis FF, Dahabreh JI. PMID: 42885117 [PubMed - indexed for MEDLINE]
	Lung Nodule Detection and False Positive Reduction Using Multi-View and Background Images. Sensors (Basel) Silva L, Pedrini H. PMID: 42884445 [PubMed - indexed for MEDLINE]
	Possible Links Between PM(2.5)-Induced NLRP3 Inflammasome Activation and Its Role in Lung Cancer Progression and Drug Resistance. Int J Mol Sci Worawichitchaikun T, Wantanachaisaeng P, Teeppaibul T, Suwannalert P. PMID: 42884173 [PubMed - indexed for MEDLINE]
	Pulmonary Carcinoid Tumors (Lung Carcinoids): Current Concepts in Diagnosis and Management. Int J Mol Sci Chan DL, Uehara Y, Kobayashi K, Tan AC. PMID: 42884110 [PubMed - indexed for MEDLINE]
	Integrated Molecular, Clinicopathological and Immune Profiling of Non-Small Cell Lung Cancer: The MONREPOS Hellenic Cooperative Oncology Group (HeCOG) Study (HE_2TR/13). Int J Mol Sci Efthymiadis K, Soteriou C, Kotoula V, Papadopoulou K, Pouliakis A, Lampaki S, Goussia A, Fountzilas E, Meditskou S, Bobos M, Kyritsis K, Lemesios C, Samantas E, Sarris E, Pentheroudakis G, Bafaloukos D, Pectasides D, Kosmidis PA, Zagouri F, Spyratos D, Timotheadou E, Hytiroglou P, Eliades A, Koumbaris G, Fountzilas G, Linardou H. PMID: 42883968 [PubMed - indexed for MEDLINE]
	The Dynamic Role of Liquid Biopsy in Patients with Non-Small Cell Lung Cancer Receiving Immune Checkpoint Inhibitors: Emerging Opportunities and Clinical Challenges. Cancers (Basel) Bazan Russo TD, Gristina V, Pepe F, Scimone C, Busuito G, Cozzolino D, Sarracino C, Ratto G, Incorvaia L, Barraco N, Badalamenti G, Galvano A, Bazan V, Russo A, Troncone G, Malapelle U. PMID: 42882934 [PubMed]
	Orthopaedic Management of Bone Metastases from Lung Cancer. Cancers (Basel) Martins Lopes J, Oliveira V, Cardoso P, Magalhães M, Fidalgo P, Araújo A. PMID: 42882922 [PubMed]
	Durvalumab Plus High-Dose Radiation in NSCLC III: Long-Term Results from the Austrian Radio-Oncological Lung Cancer Study Association Registry (ALLSTAR). Cancers (Basel) Hörmandinger K, Ruznic E, Klebermass M, Grambozov B, Feurstein P, Karner J, Gruber G, Heilmann M, Röder F, Ganswindt U, Minasch D, Zehentmayr F. PMID: 42882867 [PubMed]
	AI-Driven Multi-Omics Approaches for Deciphering Small-Cell Lung Cancer Heterogeneity Using Nucleic-Acid-Based Features. Cancers (Basel) Zeeshan S, McVey C, Majeed S, Ahmed Z, Nichols M. PMID: 42882853 [PubMed]
	Refining Lung Cancer Care: The Emerging Role of Liquid Biopsy in Screening, Diagnosis, and Precision Oncology. Cancers (Basel) Mansour H, Mazouji O, El Hammouti A, Alloubi I, Incitti R, El Kazzouli S, Ouhajjou A, Nejjari C. PMID: 42882836 [PubMed]
	A Retrospective Study of the Efficacy and Safety of Chemoimmunotherapy in Elderly Patients with Extensive-Stage Small Cell Lung Cancer. Cancers (Basel) Kobayashi M, Watanabe S, Hirose S, Watanabe H, Kushiro K, Suzuki R, Yanagimura N, Sato M, Tanaka T, Nozaki K, Saida Y, Arinami J, Goto Y, Sato K, Ishikawa D, Miyabayashi T, Ichikawa K, Matsumoto N, Koshio J, Hayashi Y, Koyama K, Makino M, Kuriyama H, Terashima R, Hashimoto A, Kikuchi T. PMID: 42882826 [PubMed]
	Early and Multimodal Care for Patients with Lung Cancer: Findings from the ACCEPT Study. Cancers (Basel) Grah C, Oei SL, Kindler F, Krabbe A, Wüstefeld H, Reif M, Thronicke A, Ngandeu Schepanski S, Seifert G, Schad F. PMID: 42882776 [PubMed]
	The Relationship Between Primary Colorectal Cancer Tumour Characteristics and Patient Outcomes Following Surgery for Oligometastatic Pulmonary Metastases: A Single-Centre Retrospective Study. Cancers (Basel) Asad A, Taylor M, Craze T, Woolf D, Raj Krishna G, Biswas S, Singhania A, Evison M, Rammohan K, Aziz O, Patel M. PMID: 42882775 [PubMed]
	Tarlatamab in Small Cell Lung Cancer and Extrapulmonary Small Cell Carcinoma: A Single-Centre Retrospective Cohort Study of Routine-Practice Outcomes. Cancers (Basel) Bangolo A, Zhang L, Zhao J, Amoozgar B, Gill S, Rajanna S, Abdelwahab S, Molina A, Robinson T, Gill U, Torres A, Akula A, Tahniyat M, Seklawi M, Vo T, Suriyaarachchi T, Castillo-Briceno O, Kalubowila S, Salorenzo T, Klechykava D, Kellman A, Roy K, Villarreal VH 2nd, Ramzan A, Haq H, Gunti R, Abaresh S, Kaur G, Montalvo J, Wang ZJ, Srivastava A, Gudiboina L, Feuer BS, Talla V, Persaud R, Noe W, Subramanian S, Weissman S, Gutierrez M, Gonzalez-Velez M. PMID: 42882773 [PubMed]
	Biomarker Integration in the Perioperative Management of Early-Stage Non-Small-Cell Lung Cancer. J Clin Med Rabinovich EP, Martin LW. PMID: 42882103 [PubMed]
	Systemic, Pleural, and Alveolar Cytokine Responses After Video-Assisted Thoracoscopic Versus Open Lobectomy for Non-Small Cell Lung Cancer: A Prospective Observational Study. J Clin Med Anc, Özercan MM, Y, Uysal S, Kumbasar U, Dikmen E, Sar, Do. PMID: 42882041 [PubMed]

Articles 1 - 20 / 162801

Page 1 of 8141



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy